| Literature DB >> 35626824 |
Agata Dobrowolska1, Małgorzata Domagalska-Szopa1, Andrzej Siwiec2, Andrzej Szopa3.
Abstract
(1) Background: Excessive body weight is a global problem in the 21st century. Children and adolescents, in particular, are at risk. Recently, there has been an increasing interest in the relationship between aerobic capacity and body composition. Therefore, this study aimed to determine the association between the individual parameters of cardiopulmonary capacity obtained in cardiopulmonary exercise testing (CPET) and selected parameters of body mass composition in high-BMI children and children over the 85th percentile according to the WHO growth reference. (2) Materials and Method: The research included 100 children of school-age (7-15 years) with an excessive BMI, i.e., over the 85th percentile as per the WHO Growth Reference (BMI percentile 95.21 ± 4.65; Z-score BMI: 2.07 ± 0.94). The study consisted of three parts: anthropometric measurements, measurement of body mass composition using a body composition analyzer (TANITA MC-780 S MA) using the bioimpedance method, and a cardiopulmonary exercise test on a pediatric cycle ergometer (Corival Pediatric, Lode BV) using the Godfrey protocol; (3)Entities:
Keywords: adolescents; body mass composition; cardiopulmonary exercise test (CPET); children; high BMI
Year: 2022 PMID: 35626824 PMCID: PMC9140148 DOI: 10.3390/children9050647
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Demographic and anthropometric parameters in the study group.
| Parameters | Group ( | ||
|---|---|---|---|
| Age (y); M ± SD, Min–Max | 11.75 ± 1.93 | 7.17–15.91 | 0.50 * |
| Height (cm); M ± SD, Min–Max | 154.00 ± 12.44 | 122.00–195.00 | 0.14 * |
| Weight (kg); Me, Q1–Q3 | 58.05 | 48.60–67.95 | 0.00 |
| BMI percentile; Me, Q1–Q3 | 95.00 | 91.95–99.60 | 0.00 |
| Z-score BMI; Me, Q1–Q3 | 1.74 | 1.40–2.62 | 0.00 |
| BMI; Me, Q1–Q3 | 23.55 | 21.80–26.85 | 0.00 |
Indications: M, mean; SD, standard deviation; Me, median; Min, minimum value; Max, maximum value; Q1, lower quartile; Q3, upper quartile; Shapiro-Wilk test p-value. * p > 0.05 indicates the normal distribution of the data.
Body mass composition parameters (Tanita test).
| Body Mass Composition Parameters | Abbreviation | Definition | Unit |
|---|---|---|---|
| Body Mass Index | BMI | Quetelet II Rate; is a value derived from the mass (weight) and height; | kg/m2 |
| Basal Metabolic Rate | BMR | it is the minimum amount of kJ needed to rest the body for 24 h to support basic life functions | kJ |
| Body Fat Percentage | BF% | Percentage of fat tissue in the body mass | % |
| Fat Mass | FM | Actual fat tissue mass | Kg |
| Fat-Free Mass | FFM | Fat-Free Mass | Kg |
| Total Body Water | TBW | Total amount of water in the body | % |
| Predicted Muscle Mass | MM | Predicted muscle mass includes skeletal muscle mass, smooth muscle mass, and water | Kg |
| Impedance | IMP | Body tissues’ electrical resistance | ohm |
| Bone Mass | BM | Predicted bone minerals mass | Kg |
| Phase angle | PA | Rate that determines health and cell integrity, is used to predict the nutritional value. | kHz |
Summary of data of body mass composition (Tanita test).
| Parameters | Group ( | ||
|---|---|---|---|
| M ± SD | Min-Max | ||
| BMR | 6388.63 ± 1260.00 | 4551.00–9977.20 | 0.91 * |
| BF% | 31.89 ± 5.65 | 13.10–48.70 | 0.97 * |
| FM | 19.72 ± 7.63 | 7.60–43.00 | 0.88 * |
| FFM | 39.89 ± 10.74 | 22.40–70.80 | 0.95 * |
| TBW | 30.21 ± 8.56 | 16.90–51.80 | 0.94 * |
| PMM | 38.44 ± 10.44 | 21.20–67.30 | 0.95 * |
| IMP | 687.77 ± 105.06 | 451.99–956.77 | 0.97 * |
| BM | 2.1 ± 0.54 | 1.20–3.50 | 0.94 * |
| PhA | 5.46 ± 0.96 | 1.70–10.56 | 0.69 * |
Indications: M, mean; SD, standard deviation; Min, minimum value; Max, maximum value; BMR, basal metabolic rate; BF%, body fat percentage; FM, fat mass; FFM, fat-free mass; TBW, total body water; PMM, predicted muscle mass; IMP, impedance; BM, bone mass; PhA, phase angle; Shapiro-Wilk test p-value. * p > 0.05 indicates the normal distribution of the data.
Summary of data of cardiopulmonary capacity (CPET).
| Parameters | Group ( | ||
|---|---|---|---|
| HR; Me, Q1–Q3 | 184.00 | 170.00–192.00 | 0.00 |
| BF; Me, Q1–Q3 | 41.00 | 36.00–51.00 | 0.00 |
| VO2peak; Me, Q1–Q3 | 1.49 | 1.22–1.79 | 0.00 |
| VO2peak/kg; Me, Q1–Q3 | 28.00 | 21.00–32.00 | 0.04 |
| W; Me, Q1–Q3 | 99.00 | 72.50–130.00 | 0.00 |
| VE; Me, Q1–Q3 | 49.30 | 41.05–60.05 | 0.00 |
| VE/VO2; M ± SD, Min–Max | 30.98 ± 4.56 | 21.90–42.30 | 0.11 * |
| VE/VCO2; Me, Q1–Q3 | 30.55 | 28.65–32.25 | 0.00 |
| RER; M ± SD, Min–Max | 1.00 ± 0.07 | 0.81–1.80 | 0.64 * |
Indications: M, mean; SD, standard deviation; Me, median; Min, minimum value; Max, maximum value; Q1, lower quartile; Q3, upper quartile; HR, Heart Rate, BF, Breathing Frequency, VO2peak, peak oxygen consumption/maximal oxygen uptake; VO2peak/kg, VO2peak per body mass; W, peak power output; VE, minute ventilation volume; VE/VO2, ventilation equivalent for oxygen; VE/VCO2, Ventilation equivalent for carbon dioxide; RER, Respiratory Exchange Ratio; Shapiro-Wilk test p-value. * p > 0.05 indicates the normal distribution of the data.
Spearman correlation between BMI and particular parameters assessing body mass composition.
| BMI | rho | |
|---|---|---|
| BF% | 0.48 | 0.00 * |
| FM | 0.83 | 0.00 * |
| FFM | 0.74 | 0.00 * |
| PhA | 0.37 | 0.06 |
Indications: * p < 0.05; rho, Spearman correlation; p value, statistical significance; BMI, body mass index; BF%, body fat percentage; FM, fat mass; FFM, fat-free mass; PhA, phase angle.
Linear regression.
| BMI as a Predictor of: | R2 | F |
| Model Equation | R2 |
|---|---|---|---|---|---|
| HR | 0.0253 | F (1,98) = 2.55 | 0.1136 | HR = 196.65 − 0.69 × BMI | 0.0253 |
| BF | 0.1089 | F (1,98) = 11.98 | 0.0008 * | BF = 65.98 − 0.9055 × BMI | 0.1089 |
| VO2peak | 0.1279 | F (1,98) = 14.38 | 0.0003 * | VO2peak = 0.34 + 0.0495 × BMI | 0.1279 |
| VO2peak/kg | 0.0629 | F (1,98) = 6.58 | 0.0118 * | VO2peak/kg = 39.83 − 0.50 × BMI | 0.0629 |
| W | 0.0001 | F (1,98) = 0.01 | 0.9170 | W = 110.50 − 0.13 × BMI | 0.0001 |
| VE | 0.0181 | F (1,98) = 1.80 | 0.1823 | VE = 34.00 + 0.69 × BMI | 0.0181 |
| VE/VEO2 | 0.0047 | F (1,98) = 0.46 | 0.4998 | VE/VEO2 = 29.01 + 0.08 × BMI | 0.0047 |
| VE/VCO2 | 0.0126 | F (1,98) = 1.25 | 0.2656 | VE/VCO2 = 27.60 + 0.10 × BMI | 0.0126 |
| RER | 0.0676 | F (1,98) = 7.10 | 0.0090 * | RER = 1.116 − 0.00 × BMI | 0.0676 |
Indications: * p < 0.05, HR, Heart Rate, BF, Breathing Frequency, VO2peak, peak oxygen consumption/maximal oxygen uptake; VO2peak/kg, VO2peak per body mass; W, peak power output; VE, minute ventilation volume; VE/VO2, ventilation equivalent for oxygen; VE/VCO2, Ventilation equivalent for carbon dioxide; RER, Respiratory Exchange Ratio.
Figure 1BMI as a predictor of VO2peak (a) and VO2peak/kg (b), BF (c), RER (d).
Spearman correlation between various parameters of body mass composition and capacity parameters.
| CPET | BMI | BF% | FM | FFM | PhA | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| rho | rho | rho | rho | rho | ||||||
| HR | −0.19 | 0.06 | −0.08 | 0.42 | −0.08 | 0.43 | −0.01 | 0.95 | −0.15 | 0.13 |
| BF | −0.36 | 0.00 * | −0.10 | 0.30 | −0.35 | 0.00 * | −0.33 | 0.00 * | −0.01 | 0.90 |
| VO2peak | 0.35 | 0.00 * | 0.06 | 0.52 | 0.36 | 0.00 * | 0.55 | 0.00 * | 0.19 | 0.06 |
| VO2peak/kg | −0.27 | 0.00 * | −0.22 | 0.03 * | −0.29 | 0.00 * | −0.13 | 0.19 | 0.06 | 0.57 |
| W | 0.04 | 0.67 | −0.04 | 0.67 | 0.11 | 0.27 | 0.29 | 0.00 * | 0.19 | 0.05 |
| VE | 0.14 | 0.15 | 0.03 | 0.76 | 0.20 | 0.04 * | 0.38 | 0.00 * | 0.15 | 0.15 |
| VE/VEO2 | 0.02 | 0.87 | 0.12 | 0.25 | 0.06 | 0.53 | 0.04 | 0.68 | −0.04 | 0.70 |
| VE/VCO2 | 0.06 | 0.57 | 0.14 | 0.15 | 0.09 | 0.37 | 0.04 | 0.66 | 0.08 | 0.42 |
| RER | −0.31 | 0.00 * | −0.15 | 0.13 | −0.28 | 0.00 * | −0.18 | 0.08 | −0.10 | 0.30 |
Indications: rho-Spearman correlation; * p < 0.05; BMI, Body Mass Index, BF%, Body Fat Percentage; FM, Fat Mass; FFM, Fat-Free Mass; PhA, Phase Angle; HR, Heart Rate, BF, Breathing Frequency, VO2peak, peak oxygen consumption/maximal oxygen uptake; VO2peak/kg, VO2peak per body mass; W, peak power output; VE, minute ventilation volume; VE/VO2, ventilation equivalent for oxygen; VE/VCO2, Ventilation equivalent for carbon dioxide; RER, Respiratory Exchange Ratio.